Digital Health Startups

Wearlinq develops the eWave, a wireless, FDA-cleared 6-lead continuous ECG cardiac monitor with a patient smartphone app and the LiveLinq platform for clinicians to review ECG waveforms and reports. Its products serve cardiologists and clinical teams for continuous cardiac monitoring and diagnostic reporting.

5 investors

Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions. The company serves healthcare providers, health plans, and patients seeking evidence-based, technology-enabled chronic care management.

5 investors

Wellth helps individuals with chronic diseases develop positive behavioral habits that improve health outcomes and quality of life. The company serves D-SNP plans and the chronic disease management market.

5 investors

Zerigo Health develops technology-driven digital therapeutics and care solutions for individuals living with chronic skin conditions. It combines device-based and data-driven approaches to support patient-centered care.

5 investors

Wheel is a virtual care platform that enables healthcare organizations and consumer health brands to deliver remote patient care through a configurable infrastructure and network of clinicians.

5 investors

XII Medical develops neuromodulation therapies for treating obstructive sleep apnea, focusing on simplifying treatment options and improving patient outcomes.

5 investors

YourPath provides mental health counseling, substance use disorder treatment, peer support, and telehealth services, including on-demand assessments, individual therapy, and group sessions. It serves individuals dealing with stress, anxiety, depression, and substance use, with services available in Kentucky.

5 investors

Zus provides a platform that removes data waste in healthcare, enabling developers, clinicians, and operators to innovate in patient and care team experience without building underlying infrastructure.

5 investors

Ichirou operates a caregiving workforce sharing platform and provides home care support and facility referral services for the elderly care market in Japan.

5 investors

Metagen Therapeutics (メタジェンセラピューティクス) is a biotech venture developing fecal microbiota transplantation (FMT) therapies and medical services based on gut microbiome research, including an FMT drug candidate (MGT-006) for ulcerative colitis. Based in Japan, it operates across drug discovery and medical services and runs a stool donation platform to source raw material.

5 investors

Welmo develops care technology products for Japan's elderly-care sector, including AI that records visits and meetings to automatically transcribe and summarize them into standardized care records. Its offerings span AI, PFM, and IoT tools aimed at reducing the workload of care workers and supporting a sustainable aging society in Japan.

5 investors

01Health provides an AI-powered platform that enables local healthcare providers to deliver specialist care by embedding clinical protocols, expert oversight, and patient workflows into their practices. The company addresses healthcare access gaps by allowing clinics to offer specialist-level treatment in-house without requiring patients to travel or wait months for appointments.

4 investors

1Doc3 offers employers an unlimited-consultation telehealth service covering general medicine, psychology, nutrition, pediatrics, sexual health, and veterinary care with no copays or wait times, aimed at improving employee wellbeing and reducing absenteeism. It adds wellness programs, step challenges, prevention campaigns, and online reporting on health program usage and impact.

4 investors

1Life Healthcare operated One Medical, a membership-based primary care organization offering in-person clinics and virtual care across the United States. Acquired by Amazon in 2023.

4 investors

52 North Health develops the patented Aster platform, a portable finger-prick blood test and companion app that measures cell-based and soluble biomarkers to identify immunosuppressed patients at risk of neutropenic sepsis. It also builds digital tools for remote triaging and management of emergency cancer care, working with patients and clinicians to make emergency care safer.

4 investors

Adaptive Biotechnologies applies the genetics of the adaptive immune system to diagnostics and therapeutics, translating immune-system data into clinical insights for clinicians and biopharma companies. Its Immune Medicine Platform is used to detect, monitor, and treat disease.

4 investors

Albus Health develops clinically validated monitoring technology that tracks respiratory metrics, heart rate, and cough frequency to support clinical studies. Its team includes clinicians, respiratory and sleep researchers, biomedical engineers, and computer scientists serving the clinical research and medical technology field.

4 investors

Alife Health develops artificial intelligence technology to modernize and personalize the in vitro fertilization (IVF) process for fertility clinics and patients.

4 investors

Aligned operates a marketplace connecting employers with independent advanced and direct primary care physicians, giving working families access to primary care benefits across multiple locations. The company aims to reduce employer healthcare costs and improve health outcomes in the United States.

4 investors

AliveCor develops digital health solutions focused on cardiovascular care, serving employers and healthcare payers seeking enterprise heart health platforms.

4 investors

ALKemist Bio develops immunotherapies targeting ALK-positive cancers, using chimeric antigen receptor (CAR) T cells and T cell receptor (TCR) engineered T cells to eliminate treatment-resistant tumors. The company focuses on oncology precision therapies for aggressive cancers including neuroblastoma and non-small cell lung cancer.

4 investors

AllClear ID Health provides patient identity management solutions for healthcare providers using mobile IDs and EHR integrations to eliminate patient record mismatching and enable digital health innovation. The platform delivers identity verification at NIST Level 2 assurance with HIPAA and CCPA compliance.

4 investors

AllStripes was a health technology company that built a research platform for rare diseases, collecting and de-identifying patients' medical records to power rare disease research. Acquired by PicnicHealth in 2022.

4 investors

Alnylam is a biopharmaceutical company that supports investigator-initiated studies in therapeutic areas including transthyretin-mediated amyloidosis, acute hepatic porphyria, and primary hyperoxaluria for medical researchers and healthcare professionals.

4 investors